GLP-1 Therapies Research Papers | Page 9 | OpenScience.ink

4 weeks ago • The lancet. Diabetes & endocrinology

Nutrition, body function, and mental health factors in incretin-based treatments for adults: Expert consensusNutritional, functional, and psychological considerations for incretin-based therapies in adults-an EASO, EFAD, and ECPO Consensus Statement.

🥇 Top 1% Journal

4 weeks ago • Scientific reports

Pregnancy outcomes linked to mothers' use of GLP-1 receptor agonist medications: a combined review and analysisPregnancy outcomes following maternal GLP-1 receptor agonist exposure: a systematic review and meta-analysis.

📖 Top 20% Journal

4 weeks ago • Cell chemical biology

Interaction between GLP-1 and GIP receptors influences insulin-releasing signalsGLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways.

🥉 Top 5% Journal

4 weeks ago • Neuroscience and biobehavioral reviews

Links Between Hormones, Appetite, and Mental Health in Older Women and What This Means for GLP-1 TreatmentThe neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy.

🥉 Top 5% Journal

4 weeks ago • Cardiovascular diabetology

Glucagon-like peptide-1 drugs and major limb problems in adults with type 2 diabetes and artery diseaseGlucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies.

🥈 Top 2% Journal

4 weeks ago • Cell metabolism

A liver enzyme changes gut stem cells to increase high blood sugarA liver phosphatase reprograms gut stem cells to drive hyperglycemia.

🥇 Top 1% Journal

4 weeks ago • Cell metabolism

GLP-1 and Fatty Liver Disease: Effects Beyond Weight LossGLP-1 and MASH: When weight loss isn't the whole story.

🥇 Top 1% Journal

4 weeks ago • Cell reports. Medicine

Preventive semaglutide and tirzepatide treatments do not change Alzheimer's disease progression in a mouse modelPreventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease.

🥈 Top 2% Journal

4 weeks ago • Drugs

Ecnoglutide: First Official ApprovalsEcnoglutide: First Approvals.

🥈 Top 2% Journal

4 weeks ago • Aesthetic plastic surgery

Computer Study of Preventive Biostimulator Treatments to Reduce Facial Sagging Linked to Weight Loss from GLP-1 DrugsComputational Trial of Prophylactic Biostimulator Interventions to Mitigate Facial Sagging Associated With GLP-1 Receptor Agonist Induced Weight Loss.

📖 Top 20% Journal

1 month ago • Circulation

Lowering Heart Disease Risk with GLP-1 Receptor Agonist DrugsCardiovascular Risk Reduction With GLP-1 RA Drugs.

🥇 Top 1% Journal

1 month ago • The Lancet regional health. Europe

Why preventing obesity is important even with new GLP-1 treatmentsThe case for primary prevention of obesity in the era of GLP-1 therapies.

🥈 Top 2% Journal

1 month ago • Therapeutic advances in endocrinology and metabolism

Heart health and biomarker changes over 2 years with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetesComparative 24-month cardiovascular outcomes and biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetes: a multicenter real-world study.

🎖️ Top 10% Journal

1 month ago • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

GLP-1 Receptor Agonist Linked to Disease Severity in Unexplained Narrowing Below the Voice BoxGLP-1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis.

📖 Top 20% Journal

1 month ago • Headache

Possible use of tirzepatide, a drug acting on two blood sugar hormones, to prevent migraines: A case seriesPotential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

🎖️ Top 10% Journal

2 days ago • Bioanalysis

Sensitive method to measure semaglutide levels in human blood plasmaDevelopment and validation of a sensitive HPLC-MS/MS method for the analysis of semaglutide in human plasma.

📖 Top 50% JournalArticle

3 days ago • International clinical psychopharmacology

Potential safety concerns and monitoring advice for lithium and GLP-1 treatments in bipolar disorderLithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations.

📖 Top 30% JournalArticle

4 days ago • Clinical nutrition ESPEN

Real-world study of how well tirzepatide works and how safe it is for people with obesityReal-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: a prospective study.

📖 Top 30% JournalArticle

5 days ago • Expert review of cardiovascular therapy

Early kidney function changes may not explain heart risk with dapagliflozin and semaglutide treatment in real-world patientsEarly changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study.

📖 Top 30% JournalArticle

5 days ago • JPEN. Journal of parenteral and enteral nutrition

Using Glucagon-Like Peptide-1 Medicines to Manage High Output Stoma in AdultsGlucagon-like peptide-1 analogues in the management of high output stoma in adult patients: A narrative review.

📖 Top 20% JournalArticle

5 days ago • Indian journal of ophthalmology

The potential benefits and challenges of diabetes drugs for treating unexplained high pressure in the brainThe emerging role of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: Therapeutic potential and challenges.

📖 Top 30% JournalArticle

1 week ago • JMIR formative research

Digital Diet Guidance and User Satisfaction During GLP-1 Treatment: A Pilot Study of a Personalized Nutrition ToolClinical Decision Support for Digital Dietary Counseling Under GLP-1 Receptor Agonist Therapy: Convergent Mixed Methods Usability and Treatment Satisfaction Pilot Study of the Personalized Nutrition Advisor.

📖 Top 30% JournalArticle

1 week ago • Journal of the Society for Cardiovascular Angiography & Interventions

Tirzepatide use and health outcomes after heart valve replacement in obese patientsAssociation of Tirzepatide Use With Clinical Outcomes After TAVR in Obese Patients: A Propensity Score-Matched Real-World Study.

📖 Top 30% JournalArticle

1 week ago • Journal of the Society for Cardiovascular Angiography & Interventions

Link Between GLP-1 Receptor Agonist Treatment Around Carotid Artery Stenting and Major Heart and Stroke Problems Within One YearAssociation of Periprocedural GLP-1 Receptor Agonist Therapy With 1-Year Major Adverse Cardiovascular Events After Carotid Artery Stenting: A Propensity-Matched Analysis.

📖 Top 30% JournalArticle

1 week ago • Journal of cardiovascular pharmacology

Incretin-based treatments, alcohol and tobacco use, and sudden substance-related heart problems: new insights for heart medicineIncretin-based therapies, alcohol and tobacco use, and acute substance-related events: emerging implications for cardiovascular medicine.

📖 Top 30% JournalArticle

1 week ago • The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons

Effects of Using Glucagon-Like-Peptide-1 Around Foot and Ankle Surgery: A Review of Comparison Studies"Examining the Impact of Perioperative Glucagon-Like-Peptide-1 use within Foot and Ankle Surgery: A Systematic Review of Comparative Studies".

📖 Top 30% JournalArticle

1 week ago • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

How Biased Signaling and Small Molecules Interact with the GLP-1 Receptor to Help Treat Type 2 Diabetes and Obesity, Based on Molecular SimulationsUnderstanding Biased Signaling and Small-Molecule Binding for Treatment of Type 2 Diabetes Mellitus and Obesity at the Glucagon-Like Peptide-1 Receptor (GLP-1R) Based on Molecular Dynamics Simulations.

📖 Top 50% JournalArticle

1 week ago • Journal of visualized experiments : JoVE

Saxagliptin with Liraglutide versus Saxagliptin Alone and Their Effects on Inflammation and Fat Hormones in Obese Type 2 Diabetes Patients Not Responding Well to MetforminSaxagliptin Combined with Liraglutide vs. Saxagliptin Alone on Microinflammation and Adipokines in Obese T2DM Patients with Poor Metformin Response.

📖 Top 50% JournalVideo-Audio Media

1 week ago • Integrative medicine research

Chinese herbal medicine versus liraglutide for weight loss in adults with obesity over 12 monthsComparative effectiveness of Chinese herbal medicine versus liraglutide for weight loss in adults with obesity: A 12-month real-world target trial emulation study.

📖 Top 50% Journal

1 week ago • International journal of cardiology. Cardiovascular risk and prevention

Comparing combined GLP-1 and SGLT2 treatments to GLP-1 alone for heart rhythm issues in non-diabetic obese patients over timeCombination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.

📖 Top 30% Journal

← prevpage 9 of 14next →